St. Marianna University School of Medicineigakukai.marianna-u.ac.jp/idaishi/www/366/06-36-2Yasuhiko...
Transcript of St. Marianna University School of Medicineigakukai.marianna-u.ac.jp/idaishi/www/366/06-36-2Yasuhiko...
![Page 1: St. Marianna University School of Medicineigakukai.marianna-u.ac.jp/idaishi/www/366/06-36-2Yasuhiko Taira.pdf · Vol. 36, pp. 521 529, 2008 : 21 2 14 A. shock ˘ˇ ˆ˙˝˛˚ ˜ !"#$˛shock](https://reader033.fdocuments.in/reader033/viewer/2022060815/609385f00377b9046e213523/html5/thumbnails/1.jpg)
� � ����������Vol. 36, pp. 521�529, 2008
������������������ ������������
����
��
���
��� :�� 21� 2� 14��
A. ����
����� shock �������������� � !"#$� shock ���� %&'()*+,-./0�����1%2 �34567�#�89�:������ � ;� septic shock �<=>>4567� ���8?����� 2
B. ���� ���
4567���� ��@A 1� 2� 9$�!"#$�A 3B-���8��CD3� 1
�� � 1������� EFGHCI�4567C��$3JK�4567LM��4567�NOP���C � 1 �Q%1��3RSTEF 90 mmHgUHC�V8$W�X
YZ[\]��^�24567�_`IaC � 2�Q%b �c�^�2d0�EFe�f�gh�ijc�^�2EF@� kl���mnop�q�Er�F�kj� )*�s�t�u%2�v�sEr�FCw�$x2�%y&� ^]�EF@Er��F�kj� �z$"�v)*�s�t�E������C{u��|%2"��@&�
�� � 2������� EFGH�I}l4567����~�� NO?����$����@�3%]�EFCb�^�
2�8���$3 ��^�3��@� EF���ij��Cx2O�"k2�� 38�EFC�����$�"?���Cxz� &�?����9����������x]�&�O������%2�8CQ$3 9����3��45678@EF�GH��&]z� 38�EF���^��"���)*t������k��4567�k28� ���k2� 2a@ Ince ]� sublingual sidestream dark-
field �SDF� imaging C����Y�¡H��v)*�E�C¢£%2� CQ$32� � 2b@ Bate-
man]�� ¤�¥¦§4�C¨!$3�©L septicshockª«¬����� multiphoton imagesC���¢£$3"J®�k2 � 2b ¯°@M�¦±²¬��sEr�³´�k2 µ°@¤�¥¦§4�¨!¶�� �sEr�³´�·¸$��v�"J®¹º�k2�8CQ%3�
�� � 3������� EFGH� )*��¹º�#$�\\']z� )�������� »¼�
� 1 Shock ������
521
9
![Page 2: St. Marianna University School of Medicineigakukai.marianna-u.ac.jp/idaishi/www/366/06-36-2Yasuhiko Taira.pdf · Vol. 36, pp. 521 529, 2008 : 21 2 14 A. shock ˘ˇ ˆ˙˝˛˚ ˜ !"#$˛shock](https://reader033.fdocuments.in/reader033/viewer/2022060815/609385f00377b9046e213523/html5/thumbnails/2.jpg)
���������� ��������1990�� Connett ��� dysoxia ���������� dysoxia �������� !"#$�%��&� �� ��'()*+ �,��-.��/� �012��� �3�4#$�4��2004 �� Spronk ��� Microcirculatory and
mitochondrial distress syndrome �MMDS� ��������� sepsis 256�789:; �mi-crocirculatory disorder� <=>?@AB:; �C�6�5��D�� 2005 �� Ince ������ �:#$3
EFGH dysoxia ��IJ KL <=>?@AB:;����� MHNO%�PQ)� R2<=>?@AB�H����:;�E��� ���������2��
C. ��������
S2TU�V�2��H���WXHKLY�&����Z[ �\��� ]H^_2��H��E�`/� a�Hbc�.256�89d.
H���e2����Hf�� gh\�3��� 89d.��2eij��Hf�����Hk_l�2mN�� ��3nY��0o��2������ ��Hf��� 3 2p��f��He���89d.2C���qr MHCs� 3 2p�� ]$�WX2ei����H�. MH�tuv���2p�� 89Ww�xyz����2 ${� |�}�W~����Hxy� ��`� 1����� �SV� CO ������ KL2��3 HR ����� SVR �W~���Ho���t�MAP ���WX� ������ ]H^_��tz��D�� pre-shock �� ��� � ]H�tuv "����3��3WXKL �3�012�4#$�� ��`�WXKL���H��z��u� E������NO2V/�]��0-.��/� WXKL�|2]H-.��_���3l�� ���] ������¡��256�89d.��HR¢� 42p�� septic shock 2��#$�Ww� ��z��HR¢�� k_25�3� CO o���SVRI KL��] ��/� ]H] £H�� ��¤�l�!��¥�� ¦§l�"¨25�3©Eª«�� ¬�U®#¯�°�YY���±����
D. �� ���������?
�� ������������� ��������� !&�K�� �&��%��H���� ²�H
1 7³H��´>B5µ�o��� ¶·� 5�10µ�§¸¹� 11µ�o�bc
2 WXKL2eij��Hº»
� ¼$522
10
![Page 3: St. Marianna University School of Medicineigakukai.marianna-u.ac.jp/idaishi/www/366/06-36-2Yasuhiko Taira.pdf · Vol. 36, pp. 521 529, 2008 : 21 2 14 A. shock ˘ˇ ˆ˙˝˛˚ ˜ !"#$˛shock](https://reader033.fdocuments.in/reader033/viewer/2022060815/609385f00377b9046e213523/html5/thumbnails/3.jpg)
���������� � ������ ������������������� � �!"�#$%&'()*� &'�+,�-.� dy-soxia /0� ���12�345�� !"�� �6�/*.789:;���*.�-�� <=��0>?@A/�BCD5�.4��*EFG dysoxia 0�/H� ���I��B
J� KL� �!"��� 12�MN5��(JOP� � &'+,�QR�-.� � S� � dysoxia ET�QR(OPJ�(UV�0�
� 2 Microcirculatory dysfunction in sepsis�septic shock
� 3 >?@A�WXYZ[\�]^_� `a�bc��XY
� 3 Z[�de*.fgshock �h�ij
� 4 k>?@A�lm.Z[\+,�no
>?@A�QR�pq 523
11
![Page 4: St. Marianna University School of Medicineigakukai.marianna-u.ac.jp/idaishi/www/366/06-36-2Yasuhiko Taira.pdf · Vol. 36, pp. 521 529, 2008 : 21 2 14 A. shock ˘ˇ ˆ˙˝˛˚ ˜ !"#$˛shock](https://reader033.fdocuments.in/reader033/viewer/2022060815/609385f00377b9046e213523/html5/thumbnails/4.jpg)
�����������
�� ��������� ������ ������ �� � 5 ����CaO2 ��������� � CvO2 �������
�� ��������� Hb � SaO2 ���� � ���!"#��$% 0.003�&'"(�)*�+��� ����,#�-�./�0�1�,), PaO2 ����� �2)*���3�456789��:�;)*�3�45�6"#���<���1��,� 9��:�;)*�3���45�� 40 mmHg ��+����= �PaO2� %�����DO2 ���>?�� �:��@�A�'B�
��:�3>?'B������ DO2 �� Hb� SaO2 ������ CaO2 � CO �C�D�� �E�7�FD'B� VO2 ���G��� ���:��G�'B������� �������HI���<��J���� VO2 �������� �CaO2��KL������� �CvO2��M�C�D��NOP���� CvO2 � PAC �pul-monary artery catheter, Swan-Ganz catheter� �7 SvO2 )*QF'B�VO2��CaO2�CvO2��CO �10 ��� 7R#VO2��S� CaO2T CO ��S��U#��>?� DO2 ��S�@P� CvO2 �VW�7R#6(� CvO2 VW���������S�X�����YZ �O2 extraction: O2ER� �� VO2�DO2�!��,� A�'BP������YZ ���� �HHI�� O2ER � 2030 ���� [��"#��\!� $� O2ER � 50]@�VW,%�"^� DO2 %_`��:�����a2b��c\�Pd� O2ER %VW,# VO2 �e��&!�fg'%�h� ,), O2ER �7�f�ij �DO2 �j(� �)k# DO2 %�S��� � 1���7^� VO2 � DO2 �l b���� *m� VO2 %_`,� �n��:���������%6(� ���oa2���p����>?�q�����)*r2b��3st,+�%uv'B� sepsis �,-�� � ���.w�7� VO2 %7�xh� @P DO2 j(%x"(�� � @P/&yz�{�0�12�7
� O2ER �7�fg'%�1�h"(����
�� ���������������34:�|}~������������ :�|}~�������J����ATP� NADH� �,#�������� aa3 ��%�� ,),� (B*�Q��}�������5�0�� tissue hypoxia � gold standard �"�BQ�67�8��"��(�� -���'B#"�%� ��=�
�����9���� � �+�����7 pH,PaO2, SaO2, HCO3, ���+��� ���A���DO2� ���G�� �VO2�, ��C��= �centralvenous pressure: CVP�, ��:;= �pulmonaryartery wedge pressure: PAWP� � SvO2� KL�����<=>� ScvO2 �C�����<=>� ��?@ pH �gastric pHi� ����� P�,(B*���J�%��A{� tissue hypoxia, dysoxia ���������"� (B*J���L�BC,��B��*�"�
E. �������������
�� �����X�HI� D�� �=� ��� ��$� �� %<����(B*�< EI¡¢�6"#£¤¥¦'B§1�¨©F��%� �n��������,������h� @Pª«¬������k�"� EGDT �early goal-directed therapy� ��G®� = �MAP: mean arterial pressure� % 6590mmHg� ¯°D��0.5 ml�kg�±�F��,#"6��@P�=��7�!"#�� ²³����´µmanometer 7���¶·|�¸¹º�7*»
� 5 ������ ���
G ¼H524
12
![Page 5: St. Marianna University School of Medicineigakukai.marianna-u.ac.jp/idaishi/www/366/06-36-2Yasuhiko Taira.pdf · Vol. 36, pp. 521 529, 2008 : 21 2 14 A. shock ˘ˇ ˆ˙˝˛˚ ˜ !"#$˛shock](https://reader033.fdocuments.in/reader033/viewer/2022060815/609385f00377b9046e213523/html5/thumbnails/5.jpg)
��������� ��� ��������������� ��� �MAP: mean arterial pres-sure� ������� !��Antonelli "#� $%&'�()*+�#� �,
� ���-�./01� 2�� �345��6�7)89���:� ;<= >?�������:<7��
�� ���������@ABCDE ��/@A- dysoxia �FG�
��6�# � pH, PaO2, SaO2, HCO3, ���HI�� ?� J� SaO2 9 PaO2 #@AK�LM�N�OH�PQRSHI���@ABCDE�TU� JV@W#PQR
SHI�� septic shock �TU� JV@����X! YZ�� � 4�[\�VO2 �@A]^�� #_`�HI�� DO2 �@A
ab�� �cdH#Q!� @AeK� �O2 extrac-tion: O2ER� #� VO2�DO2 �fH�:� ab�<@A��H�eK��g�� �445H�O2ER # 20�30� HI�� h Q�i��jX�kE O2ER # 50�l;Hmn:o�9!)� DO2�pq��9r���H�stuBCvj�<w� O2ER �mn: VO2 �`���XBxyz
�{|� :}: O2ER ���Bx�~� �DO2 ����� ��� DO2 �/���9� � 4�g��)� VO2 # DO2 ���u9Q�� ��>�VO2 �pq:� �.��r�H�@ABCDE�T8�� �Q��stBC}"�tuBC��7:V@������ septic shock ���#� ��BC����� VO2 ����|� ;< DO2 ������!89� � ;<��01��?������� O2ER mn���Bxyz�{��|!89HI�� ��Hg:< septic shock �T! �DO2 ������� pq:<�w���9�H��@A]^��g�������9����tuBC� �Q��V@��������BCu�$��$ � ��V@�$��$ �PHI�� ¡¢���TU�@ABCDE�RS9: �JV@W��£>�#¤|�!" !��P¥*+��¦��9§�¨©ª�� JV@W#��9��«�I�8�� JV@W¬����� ¬�����¦®�¯°HI�9��«I�9��Antonelli "#� $%&'�TU�01?5±²³´µ¶�X! � �/���·�¸�9: � ScvO2 ;<# SvO2 �/�� �V@ ¥� base
� 4 @A���]^���¹�TU� DO2, VO2, O2ER ¬: V@���
$%&'�º»��¼ 525
13
![Page 6: St. Marianna University School of Medicineigakukai.marianna-u.ac.jp/idaishi/www/366/06-36-2Yasuhiko Taira.pdf · Vol. 36, pp. 521 529, 2008 : 21 2 14 A. shock ˘ˇ ˆ˙˝˛˚ ˜ !"#$˛shock](https://reader033.fdocuments.in/reader033/viewer/2022060815/609385f00377b9046e213523/html5/thumbnails/6.jpg)
deficit ���� pH ��������7��2008�� Bakker�� “Don’t take vitals, take alactate” �� ���� �������������������������� �� �!"#10��$����������%&���'��
�� ()*+�,���'����-�� .����/0�����'1�������2�)��� ���3("4�-� 56�� ����!��-7���89"#�$% �re-distribution�:;�&4� ���'(<����)� *()=�> +���#�9$%?�� *�*�,@AB�CD-EFDG��� .�����%���8"#�.H56� �����'/��I$��)�J��01�� Microdialysis 2��3��KL8MN2��4��5���/0���67�� �����OP�8QR9���� LPS :;STUV��%��� /0��<������WX=>����YZ�� ��������,���'����[(����\)�]�[(^_�?��� `a@bc4�dY�#11��
�� ����� CVP: central venous pressureefgABh ��i<CD� preload��jE���4��� J����(J��()*+ CO���� DO2 ���k)��� �����'�lm�;n� EGDT �� 8�12 mmHg �1E������g�� 1992 �� Lichtwarck-Ascho# 12��2001�� Marik� CVP��i<CD�jE����F4G�H7�#13��
�� ���� PAWPPAC �Pulmonary artery catheter� Swan-Ganz
catheter� ���o6?�� I�J�KL�pq�r�#67s�tMs��2�s�CD�NuOP�vk�� w7�x7#v��� preload �[(jE���O4?��4#� �g�� Marik �� CVP � preload ��i<CD� ����Py�-�=>�� PAWP �-f �tz{Q|}s�LVEDP� �jE�-�� preload ��i<CD� �[~(tz{Q|}CD �LVEDV� �jE��)��!"��8�� J�� LVEP �s�� LVEDV�CD� ��$7�NuOP�-����� *�
compliance� *(R��� S����� PEEP,��<s� ���*T�<s)=�-4flm?�g�-12� 13��
�� ���� ����� �SvO2�� ��������������� �ScvO2�SvO2 ����� � Hb �� ��DO2 ���� �
SaO2 �J���U�� �� ��DO2 ���� �*V�D CO �� ��DO2���� � VO2 ��WXDY����(� ��ZJ��|K��J�[\(� ��>���{���|K��J����%s40 mmHg���'�� J�����]�Ng��U�� 70����[\(����>���{��^_(jE�v)� EGDT �� SvO2�70��`7�#��� 1k�-� �
�� gastric pHi�aT� pH�-� �aT����/����aT/0� pHi ���(� .H56 �/���� �#9$%���W�i� b(� ���)=�c7+��#���(���-� J��n�aT< pH �pHi� �/0����'/���2(�� ��(<����.H56 ��d}jE���e4?��$�� Antonelli� gastric pHi������ 4(J����?�)���#7�����¡�f¢��jE�-�� ���vfg������'\h�£i�4v��)f� J�jE���j�kl("4�-�
F. sepsis, severe shock, septic shock ����
�� SIRS �systemic inflammatory response syn-drome: ������ �!"��3�<m6¤�n(¥oG�-¦mg�§¨©ª«�p¬�� � �3�p¬�&�� �3�<m6¤�®¯(#Z��3q°�c��J(� �3q°�c��rj)v��±��c�-� p¬�&#�3��3q°�#Z��J�#±��c�/0�² ���G�±��c�³��#/�� SIRS �-� SIRS �´�sL� 1k� humoral mediator, cytokine�-� ��µ¶���tu�3�·hG®¯�#Z�&f�� p¬���1v�,�?�� ¸4�Y¹�� ��µ¶��º»µ¼�p�uw���3<g�3·hG®¯
x yz526
14
![Page 7: St. Marianna University School of Medicineigakukai.marianna-u.ac.jp/idaishi/www/366/06-36-2Yasuhiko Taira.pdf · Vol. 36, pp. 521 529, 2008 : 21 2 14 A. shock ˘ˇ ˆ˙˝˛˚ ˜ !"#$˛shock](https://reader033.fdocuments.in/reader033/viewer/2022060815/609385f00377b9046e213523/html5/thumbnails/7.jpg)
����������� � SIRS ���� ��������������� TNF-a, IL-1, IL-6,IL-8 �������SIRS �� !"�� 5#$�� 4%��&' 2
%�()� SIRS �� *�� �+#��,-�./�,-0����� 1991 �# American Col-lege of Chest Physicians � Society of Critical CareMedicine � 2 123�34562 �ACCP �SCCM Consensus Conference�78*� ��2� sepsis, SIRS, sepsis9�:��;<�=>?� @�AB�CDE�F��G��H�IJKI*B14� 15��
�� SepsisLMNOPQR� 1 S���� LM#TU��
SIRS � sepsis �IJ��� � 5� V���W��� #XW>#YZ�[<EZP�\���]�^�_`����[<�����B� ��XZW�E]�^�_`�W��*� sepsis �-&0�#�a*�� sepsis �� #W�>�YZ�b�X���� SIRS �c��LMd�N�e sepsis �� *�14� 15��f� sepsis �severe sepsis� �X� sepsis #�gh`^i`j� ��� k�4lmn��opq��rEst�r��&N�����septic shock �Xf� sepsis �u�f�v�� �
w��x?�#uy�NWz�{|� }� ~W��!"�������:���� �BWz��*�Nopq�mnEst�r[����:�*��
G. EGDT � SSC
�� Early goal-directed therapy �EGDT���� severe sepsis, septic shock #C������O#1����i���-�?����)����B� -}N$�-��� ���yB16� 17��2001 �� Rivers �X� ���%��!#� �
CVP� �MAP, ��&� � SvO2 or ScvO2� ����i�i������� ��#?�'��(���I�B� ������%�� bundle �G���ICU )��� ER � 6 �.(*#���%���bundle����������#uy� severe sepsis� septic shock �?�����)*�B���%��B� � EGDT ���6��Rivers ���$�B EGDT �V��?�+�control ��� Standard therapy ���� ������ 6#$��EGDT �, Xst!:�¡I¢���� -£
¤¥.��{|� ��¦'-£¤¥g\ §�{|������� EGDT ¨�/©XV��?�+�standard therapy� ��ª00#�I*�-B CVP, MAP,�&#«¬�� ¤¥g\®�¯1��(��� ScvO2 �SvO2��70� ��I%�#°«�B������ -£¤¥g\ §�2±���{|#u�f3�²-B?�+��y�-��
�� SSC �Surviving sepsis campaign guidelines�SCC 2004 X� sepsis ?���)�������
11 �³k�=>?��´µ�12� �� ���#%�*B sepsis?�#9��%��45�
� 5 SIRS �Systemic Inflammatory Response Syndrome r¶���6·�¸¨� �0��� !"
`¹º»�0��7¼ 527
15
![Page 8: St. Marianna University School of Medicineigakukai.marianna-u.ac.jp/idaishi/www/366/06-36-2Yasuhiko Taira.pdf · Vol. 36, pp. 521 529, 2008 : 21 2 14 A. shock ˘ˇ ˆ˙˝˛˚ ˜ !"#$˛shock](https://reader033.fdocuments.in/reader033/viewer/2022060815/609385f00377b9046e213523/html5/thumbnails/8.jpg)
����� 19 ������������ ����������� grading����������� evidence ������� !�"��#$%&��� '�( 2004)� Critical Care Medicine *� Intensive Care Medicine *�+,�-.&��18� 19�� SSC ( A /0 S 1� 19����2� �����3�# A /0 E 1������45��� SSC �67��� A. Initial Resuscitation (89:;�<5=��>� EGDT (��?@�AB#��18� 19��SSC 2004 �C.D� EF?�GH�IJK�guideline �LB�M��NI��� ��OP�QR�� 2008 )�STU SCC 2008 KC.&���SSC 2008 �2��� 7�VW20� 21��
XY� Z�Z�Q?M�[ �intensivist� (� se-vere sepsis � septic shock ���� evidence based
medicine �\]���� !�"�^_�33�experience based medicine�`a#'�0\bc;�M��d>ef���
H. ���
1� ghij�(�kelmnopqr����2� st�uv��B#ghij�wx����(M�KDy�z��3� ghij��;���� �kel��qr�
elmnopqr�{|w}��~�� �����K��� ��������ghij�{|wx�W��(����� ������������W��K���4� ghij���(89:;���H���initial resuscitation ��OW�����>���� ����5� SIRS �(���b��b����>� ��
���r�� ��~����¡¢£� 13����b��K���¤f¥¦;���� §�¨©��# humoral mediator,ª� cytokine K\����6� sepsis �(«¬��W�� 1�(�®W�SIRS ����7� SSC �Surviving Sepsis Campaign� �(\b
sepsis� septic shock�M�%¯°���~�EF�A sepsis M��±���� �)��ST&���8� EGDT �Early goal-directed therapy� �(�SSC� I Management of severe sepsis�²³�AWM�´±����
� 6 EGDT �µ¶�J5�·¸Usual care � EGDT �¹º
� 7 SSC 2008�2�
� »¼528
16
![Page 9: St. Marianna University School of Medicineigakukai.marianna-u.ac.jp/idaishi/www/366/06-36-2Yasuhiko Taira.pdf · Vol. 36, pp. 521 529, 2008 : 21 2 14 A. shock ˘ˇ ˆ˙˝˛˚ ˜ !"#$˛shock](https://reader033.fdocuments.in/reader033/viewer/2022060815/609385f00377b9046e213523/html5/thumbnails/9.jpg)
� �
1� ���� “������� �” ����1990; 14: 1332�
2� Ince, C. “The microcirculation is the motor ofsepsis.” Crit Care 2005; 9 Suppl 4: S13�S19.
3� Bateman, RM and Walley, KR �2005�.“Microvascular resuscitation as a therapeutic
goal in severe sepsis.” Crit Care 9 Suppl 4: S27�S32.
4� Connett, RJ, Honig, CR, Gayeski, TE, et al.“Defining hypoxia: a systems view of VO2,
glycolysis, energetics, and intracellular PO2.” J
Appl Physiol 1990; 68: 833�842.5� Spronk, PE. “Microcirculatory and mitochon-drial distress syndrome �MMDS�: a new look atsepsis.” Update in Intensive Care Emergency
Medicine 2004; 42: 47�69.6� Rivers, E, Nguyen, B, Havstad, S, et al. “Earlygoal-directed therapy in the treatment of severe
sepsis and septic shock.” N Engl J, Med 2001;
345: 1368�1377.7� Antonelli, M, Levy, M, Andrews, P, et al. “He-modynamic monitoring in shock and implica-
tions for management International Consensus
Conference, Paris, France, 27�28 April 2006.”Intensive Care Med 2007; 33: 575�590.
8� Cooper, N and Forrest, K. Essential Guide toAcute Care. Baltimore 2006.
9� Bakker, J, Co#ernils, M, Leon, M, et al.“Blood lactate levels are superior to oxygen-
derived variables in predicting outcome in hu-
man septic shock.” Chest 1991; 99: 956�962.10� Bakker, J and Jansen, TC. “Don[t take vitals,take a lactate.” Intensive Care Med 2007; 33:
1863�1865.11� ���� “������������ !" Microdialysis #$%&'()*+,-./�01�” 2����34 2006; 12: 460.
12� Lichtwarck-Ascho#, M, Zeravik, J and
Pfei#er, UJ. “Intrathoracic blood volume ac-
curately reflects circulatory volume status in
critically ill patients with mechanical ventila-
tion.” Intensive Care Med 1992; 18: 142�147.13� Marik, P. Handbook of Evidence-Based Criti-cal Care. New York, Springer-Verlag. 2001.
14� “American College of Chest Physicians�Societyof Critical Care Medicine Consensus Confer-
ence: definitions for sepsis and organ failure
and guidelines for the use of innovative thera-
pies in sepsis.” Crit Care Med 1992; 20: 864�874.
15� Bone, RC, Balk, RA, Cerra, FB, et al. “Defin-itions for sepsis and organ failure and guide-
lines for the use of innovative therapies in sep-
sis. The ACCP�SCCM Consensus ConferenceCommittee. American College of Chest Physi-
cians�Society of Critical Care Medicine.” Chest1992; 101: 1644�1655.
16� Gattinoni, L, Brazzi, L, Pelosi, P, et al. “Atrial of goal-oriented hemodynamic therapy in
critically ill patients. SvO 2 Collaborative
Group.” N Engl J Med 1995; 333: 1025�1032.17� Hayes, MA, Timmins, AC, Yau, EH, et al.
“Elevation of systemic oxygen delivery in the
treatment of critically ill patients.” N Engl J
Med 1994; 330: 1717�1722.18� Dellinger, RP, Carlet, JM, Masur, H, et al.
“Surviving Sepsis Campaign guidelines for
management of severe sepsis and septic shock.
” Crit Care Med 2004; 32: 858�873.19� Dellinger, RP, Carlet, JM, Masur, H, et al.
“Surviving Sepsis Campaign guidelines for
management of severe sepsis and septic
shock.” Intensive Care Med 2004; 30: 536�555.20� Dellinger, RP, Levy, MM, Carlet, JM, et al.
“Surviving Sepsis Campaign: international
guidelines for management of severe sepsis and
septic shock: 2008.” Intensive Care Med 2008;
34: 17�60.21� Dellinger, RP, Levy, MM, Carlet, JM, et al.
“Surviving Sepsis Campaign: International
guidelines for management of severe sepsis and
septic shock: 2008.” Crit Care Med 2008; 36:
296�327.
�����56�78 529
17